Social Pulse: Daxor Corp (DXR)
DXR on American Stock Exchange
7.47USD
17 May 2013
7.47USD
17 May 2013
Price Change (% chg)
$-0.02 (-0.27%)
$-0.02 (-0.27%)
Prev Close
$7.49
$7.49
Open
$7.48
$7.48
Day's High
$7.48
$7.48
Day's Low
$7.47
$7.47
Volume
338
338
Avg. Vol
1,329
1,329
52-wk High
$9.50
$9.50
52-wk Low
$7.06
$7.06
- 4 Obscure Healthcare Stocks To Watch In 2013
- 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part II
- Top February Dogs: 8 Venerable Indices Flaunt 19% To 41.5% Annual Gains
- Yahoo Sector Dogs Sport 7% To 17% Gains In February
- 8 Sectors And Dow 'Septober' Dividend Dog Report
- 5 Healthcare Companies With Insider Buying During October 2012
Press Releases
- Daxor Corporation Announces Payment of a Dividend
- Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume Analyzer
- Daxor Announces Basic Blood Volume Research Study on Renal Dialysis Patients
- Study at Columbia University Using Blood Volume Analyzer Demonstrates Hidden Polycythemia in Heart Failure Patients
- Daxor Corporation Announces Filing of Form N-CSR for June 30, 2012 and Volumex Kit Sales for the First Six Months of 2012
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
